Arovella Therapeutics

Popular Searches:

Your Previous Searches:

Recently Visited Pages:

Home
Sparks
Equities
Equities
View All Equities
Equities by Sector

Consumer

Energy & Resources

Financials

Healthcare

Industrials

Investment Companies

Metals & Mining

Real Estate

TMT

The Schiehallion Fund

MCap

USD2,237m

Last close

USD2.16

▲ −0.02 (−0.92%)

Metals One

MCap

—

Last close

GBP0.01

▲ 0.18 (19.44%)

Filtronic

MCap

GBP566m

Last close

GBP2.72

▲ 15.00 (5.84%)
Sectors
Sectors
View All Sectors
Megatrends
Megatrends
- Artificial intelligence
Thematics
Thematics
View All Thematics

Latest
Audiovisual
Audiovisual
View All Audiovisual

Latest

Events
About Edison
About Edison
Corporates

Investors

Careers

“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”

Edison Client
Equity Research
Investor Relations
Contact us

Arovella Therapeutics (ASX: ALA)

Last close As at 02/10/2026

—

— 0.00 (0.00%)

Market capitalisation

—

Overview
Research
Thematics

Arovella Therapeutics is a biotechnology company focused on developing therapies to treat cancer and conditions that affect the central nervous system.